The debate over drug pricing has featured complicated arguments over profit, innovation, and fairness. At the end of the day, it’s all about patients being able to afford medicine—and Monday brought one of the biggest victories yet on that front.
Trending:
Opinion: Cheaper insulin is a big victory for patients